Synergy CHC Corp. (Uplisting) (SNYR) Competitors $3.87 -0.01 (-0.26%) As of 02/21/2025 01:40 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsTrends SNYR vs. RENB, TELO, CRBU, IZTC, MIST, VTYX, VIRI, IFRX, EPRX, and SAVAShould you be buying Synergy CHC Corp. (Uplisting) stock or one of its competitors? The main competitors of Synergy CHC Corp. (Uplisting) include Renovaro (RENB), Telomir Pharmaceuticals (TELO), Caribou Biosciences (CRBU), Invizyne Technologies (IZTC), Milestone Pharmaceuticals (MIST), Ventyx Biosciences (VTYX), Virios Therapeutics (VIRI), InflaRx (IFRX), Eupraxia Pharmaceuticals (EPRX), and Cassava Sciences (SAVA). These companies are all part of the "pharmaceutical products" industry. Synergy CHC Corp. (Uplisting) vs. Renovaro Telomir Pharmaceuticals Caribou Biosciences Invizyne Technologies Milestone Pharmaceuticals Ventyx Biosciences Virios Therapeutics InflaRx Eupraxia Pharmaceuticals Cassava Sciences Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) and Renovaro (NASDAQ:RENB) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends. Does the media favor SNYR or RENB? In the previous week, Renovaro had 2 more articles in the media than Synergy CHC Corp. (Uplisting). MarketBeat recorded 2 mentions for Renovaro and 0 mentions for Synergy CHC Corp. (Uplisting). Renovaro's average media sentiment score of 0.91 beat Synergy CHC Corp. (Uplisting)'s score of 0.00 indicating that Renovaro is being referred to more favorably in the news media. Company Overall Sentiment Synergy CHC Corp. (Uplisting) Neutral Renovaro Positive Which has higher earnings and valuation, SNYR or RENB? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynergy CHC Corp. (Uplisting)N/AN/AN/AN/AN/ARenovaroN/AN/A-$80.65M-$0.93-0.89 Do analysts rate SNYR or RENB? Synergy CHC Corp. (Uplisting) currently has a consensus price target of $10.00, suggesting a potential upside of 158.40%. Given Synergy CHC Corp. (Uplisting)'s stronger consensus rating and higher probable upside, equities analysts plainly believe Synergy CHC Corp. (Uplisting) is more favorable than Renovaro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC Corp. (Uplisting) 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Renovaro 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor SNYR or RENB? Synergy CHC Corp. (Uplisting) received 2 more outperform votes than Renovaro when rated by MarketBeat users. CompanyUnderperformOutperformSynergy CHC Corp. (Uplisting)Outperform Votes2100.00% Underperform VotesNo VotesRenovaroN/AN/A Do insiders & institutionals believe in SNYR or RENB? 71.4% of Renovaro shares are owned by institutional investors. 21.7% of Renovaro shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is SNYR or RENB more profitable? Synergy CHC Corp. (Uplisting)'s return on equity of 0.00% beat Renovaro's return on equity.Company Net Margins Return on Equity Return on Assets Synergy CHC Corp. (Uplisting)N/A N/A N/A Renovaro N/A -61.84%-48.07% SummarySynergy CHC Corp. (Uplisting) beats Renovaro on 7 of the 11 factors compared between the two stocks. Get Synergy CHC Corp. (Uplisting) News Delivered to You Automatically Sign up to receive the latest news and ratings for SNYR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNYR vs. The Competition Export to ExcelMetricSynergy CHC Corp. (Uplisting)Medicinals & botanicals IndustryStaples SectorNASDAQ ExchangeMarket Cap$33.73M$1.16B$16.88B$9.14BDividend YieldN/AN/A2.89%3.85%P/E RatioN/A35.7816.4719.11Price / SalesN/A5.725.3576.36Price / CashN/A10.4016.3834.83Price / BookN/A1.926.914.62Net IncomeN/A-$53.22M$737.40M$245.85M7 Day Performance4.59%-5.53%-0.43%-2.61%1 Month Performance-5.84%-1.92%0.91%-2.14%1 Year PerformanceN/A-13.79%9.66%12.98% Synergy CHC Corp. (Uplisting) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNYRSynergy CHC Corp. (Uplisting)N/A$3.87-0.3%$10.00+158.4%N/A$33.73MN/A0.0040Negative NewsGap UpRENBRenovaro0.763 of 5 stars$0.81+9.0%N/A-61.1%$128.39MN/A-0.8420Earnings ReportNews CoverageGap UpTELOTelomir Pharmaceuticals2.2818 of 5 stars$4.29+0.5%N/A-54.8%$127.67MN/A-7.401Analyst ForecastNews CoverageCRBUCaribou Biosciences3.1342 of 5 stars$1.35+3.1%$10.33+665.4%-80.8%$122.25M$11.48M-0.82100Gap UpIZTCInvizyne TechnologiesN/A$19.42+0.7%N/AN/A$121.38MN/A0.00N/AMISTMilestone Pharmaceuticals2.8119 of 5 stars$2.27-0.9%$13.00+472.7%+29.1%$121.06M$1M-2.8030VTYXVentyx Biosciences3.1131 of 5 stars$1.71+1.8%$10.00+484.8%-68.1%$120.92MN/A-0.7230Upcoming EarningsVIRIVirios TherapeuticsN/A$6.13-8.6%$3.00-51.1%+1,411.6%$118.05MN/A-22.705IFRXInflaRx3.2978 of 5 stars$2.00-25.9%$8.00+300.0%+21.9%$117.76M$70,000.00-1.8560Gap DownHigh Trading VolumeEPRXEupraxia Pharmaceuticals3.4167 of 5 stars$3.28+1.2%$9.00+174.4%N/A$116.83MN/A-4.5629Analyst ForecastShort Interest ↓News CoverageHigh Trading VolumeSAVACassava Sciences3.7798 of 5 stars$2.42+1.7%$111.50+4,507.4%-88.5%$116.43MN/A-1.7530Gap Up Related Companies and Tools Related Companies Renovaro Competitors Telomir Pharmaceuticals Competitors Caribou Biosciences Competitors Invizyne Technologies Competitors Milestone Pharmaceuticals Competitors Ventyx Biosciences Competitors Virios Therapeutics Competitors InflaRx Competitors Eupraxia Pharmaceuticals Competitors Cassava Sciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SNYR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synergy CHC Corp. (Uplisting) Please log in to your account or sign up in order to add this asset to your watchlist. Share Synergy CHC Corp. (Uplisting) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNYR Stock Alerts